Ultrasonic Neuromodulation for Treatment of Cognitive Impairment
Key facts
- Who runs it
- University of Utah
- Where
- Salt Lake City, United StatesSee the site
- Trial code
- Status
- Terminated
- Phase
- Phase 1/2
- People taking part
- 1 person enrolled
- Started
- 18 Aug 2024
- Ended
- 21 Aug 2024
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Diadem prototype
- Record updated
- 25 May 2025
- Why it stopped
- IRB administrative closure
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Mild cognitive impairment or mild dementia due to Alzheimer's disase (AD) with confirmed AD biomarkers (Amyloid PET or CSF)
- Age 65-80
- MOCA > 18
Who cannot take part
- Evidence of cerebral amyloid angiopathy or stroke within 1 year
- Clinical symptoms or findings suggestive of alternative diagnosis or co-pathology
- Inability to complete MRI
- Suicidal ideation
Where in United States
- University of UtahSalt Lake City, United States
About the trial
What the trial wants to find out
This study will evaluate a new form of non-invasive deep brain therapy for individuals with Alzheimer's disease. Low-intensity transcranial focused ultrasound stimulation will first be delivered using a range of stimulation parameters during psychophysical and physiological monitoring. A well-tolerated stimulation protocol will be selected for subsequent testing in a blinded randomized sham-controlled cross-over trial. The trial will evaluate brain target engagement using magnetic resonance imaging, PET imaging, and numerical scales of cognitive performance.
The 2 groups in the trial
- Active stimulationTreatment being tested
Low-intensity transcranial focused ultrasound stimulation of deep brain targets affected by Alzheimer's disease.
Treatment: Diadem prototype
- Sham stimulationSham treatment, for comparison
Sham stimulation that applies the device in the same way as verum but only delivers auditory sounds correspoding to the ultrasonic pulses.
Treatment: Diadem prototype
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Deep Brain Therapy With Low-intensity Ultrasound for Treatment of Cognitive Impairment
- Record updated
- 25 May 2025